Journal of Clinical Oncology
Journal · Lippincott Williams & Wilkins · ISSN 0732-183X
174,214 papers · 4,515,307 citations · h-index 744 · impact 1.8
Journal websiteOpenAlexLung Cancer Treatments and MutationsCancer Treatment and PharmacologyCancer Genomics and DiagnosticsColorectal Cancer Treatments and StudiesCancer Immunotherapy and BiomarkersProstate Cancer Treatment and Research
Latest papers
- Reply to: “Creatinine Assay Methods and Carboplatin Dosing Transparency in the neoCARHP Trial”David Cucchiari, Paolo Tarantino · Journal of Clinical Oncology · 2026
- Creatinine Assay Methods and Carboplatin Dosing Transparency in the neoCARHP TrialYuichi Ando, Tomoya Shimokata · Journal of Clinical Oncology · 2026
- Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract CancerMasafumi Ikeda, Kohei Nakachi, Masaru Konishi et al. · Journal of Clinical Oncology · 2026
- Reply to: “Creatinine Assay Methods and Carboplatin Dosing Transparency in the neoCARHP Trial”Hongfei Gao, Wei Li, Jie Dong et al. · Journal of Clinical Oncology · 2026
- Transcriptomic Plasticity and Its Spatial Architecture Shape Melanoma Response to Immunotherapy and Its Combination With BRAF/MEKiKalpit Shah, Dieu An H. Nguyen, Maxwell P. Gold et al. · Journal of Clinical Oncology · 2026
- When Survival SeparatesCourtney Hall · Journal of Clinical Oncology · 2026
- Patient-Level Evaluation of Optimal Margin Width for Lumpectomy in Ductal Carcinoma In Situ: An Analysis of Patients in the National Cancer Database Special StudyAmanda L. Nash, Yan Li, Samantha Marie Thomas et al. · Journal of Clinical Oncology · 2026
- Association Between Patient-Reported Outcomes and Health Care Resource Utilization: Toward Developing Patient-Centered Value Measures in Cancer CareDhruvin H. Hirpara, Andreea C. Matei, Rinku Sutradhar et al. · Journal of Clinical Oncology · 2026
Most cited
- The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.David F Cella, David S. Tulsky, Geoffrey V. Gray et al. · Journal of Clinical Oncology · 19936,105cited
- Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 19975,936cited
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano ClassificationBruce D. Cheson, Richard I. Fisher, Sally Fiona Barrington et al. · Journal of Clinical Oncology · 20145,727cited
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic SubtypesJoel S. Parker, Michael Eugene Mullins, Maggie C.U. Cheang et al. · Journal of Clinical Oncology · 20094,974cited
- Final Version of 2009 AJCC Melanoma Staging and ClassificationCharles M. Balch, Jeffrey E. Gershenwald, Seng-Jaw Soong et al. · Journal of Clinical Oncology · 20094,621cited
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United StatesJames C. Yao, Manal M. Hassan, Alexandria T. Phan et al. · Journal of Clinical Oncology · 20084,566cited
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerAntonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz et al. · Journal of Clinical Oncology · 20064,487cited
- Revised Response Criteria for Malignant LymphomaBruce D. Cheson, Beate Pfistner, Malik Eid Juweid et al. · Journal of Clinical Oncology · 20074,468cited
Profile assembled from OpenAlex, the open catalog of scholarly work. Metrics reflect OpenAlex’s coverage and may differ from other databases; “impact” is OpenAlex’s two-year mean citedness, comparable to a journal impact factor.
Your own research deserves this workspace
Search and screen literature, follow authors and journals, analyze your data, and write in your own voice — in one place.